Susquehanna International Group’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$99.3K Buy
61,300
+4,900
+9% +$10.1K ﹤0.01% 12350
2025
Q4
$158K Sell
56,400
-38,900
-41% -$90.3K ﹤0.01% 11120
2025
Q3
$196K Buy
95,300
+53,600
+129% +$148K ﹤0.01% 11010
2025
Q2
$131K Buy
41,700
+10,400
+33% +$31.7K ﹤0.01% 11604
2025
Q1
$98.3K Sell
31,300
-13,700
-30% -$54.2K ﹤0.01% 11549
2024
Q4
$195K Buy
45,000
+8,500
+23% +$26.6K ﹤0.01% 10750
2024
Q3
$97.5K Buy
36,500
+9,700
+36% +$22.9K ﹤0.01% 11068
2024
Q2
$59.5K Buy
26,800
+7,300
+37% +$27.5K ﹤0.01% 11333
2024
Q1
$104K Sell
19,500
-8,500
-30% -$22.6K ﹤0.01% 11192
2023
Q4
$41.4K Sell
28,000
-19,500
-41% -$23.6K ﹤0.01% 11785
2023
Q3
$66K Buy
+47,500
New +$80.1K ﹤0.01% 11166
2023
Q2
Sell
-57,300
Closed -$94.5K 12200
2023
Q1
$94.5K Buy
57,300
+42,100
+277% +$72.3K ﹤0.01% 11341
2022
Q4
$21.3K Sell
15,200
-29,500
-66% -$42.2K ﹤0.01% 11746
2022
Q3
$69K Buy
44,700
+6,600
+17% +$15.9K ﹤0.01% 11997
2022
Q2
$84K Sell
38,100
-29,400
-44% -$49.2K ﹤0.01% 11628
2022
Q1
$167K Sell
67,500
-40,600
-38% -$144K ﹤0.01% 11450
2021
Q4
$650K Sell
108,100
-88,100
-45% -$525K ﹤0.01% 8453
2021
Q3
$1.31M Sell
196,200
-21,500
-10% -$135K ﹤0.01% 6856
2021
Q2
$1.45M Sell
217,700
-87,100
-29% -$739K ﹤0.01% 6744
2021
Q1
$2.82M Buy
304,800
+76,100
+33% +$925K ﹤0.01% 5101
2020
Q4
$4.11M Buy
228,700
+128,400
+128% +$2.26M ﹤0.01% 3756
2020
Q3
$1.42M Buy
+100,300
New +$662K ﹤0.01% 5279
2017
Q2
Sell
-671
Closed -$56K 9254
2017
Q1
$56K Sell
671
-82
-11% -$11.1K ﹤0.01% 8569
2016
Q4
$114K Sell
753
-37
-5% -$8.64K ﹤0.01% 9011
2016
Q3
$255K Sell
790
-1,028
-57% -$375K ﹤0.01% 7194
2016
Q2
$593K Sell
1,818
-533
-23% -$184K ﹤0.01% 5843
2016
Q1
$787K Sell
2,351
-581
-20% -$198K ﹤0.01% 5561
2015
Q4
$1.14M Sell
2,932
-178
-6% -$69.7K ﹤0.01% 5144
2015
Q3
$1.27M Buy
3,110
+1,300
+72% +$680K ﹤0.01% 5179
2015
Q2
$1.32M Buy
1,810
+1,245
+220% +$883K ﹤0.01% 5590
2015
Q1
$277K Buy
+565
New +$241K ﹤0.01% 8116

Other funds holding CRDF